Medicover AB
STO:MCOV B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medicover AB
STO:MCOV B
|
SE |
|
O
|
One Media Group Ltd
HKEX:426
|
HK |
|
Jai Balaji Industries Ltd
NSE:JAIBALAJI
|
IN |
|
Western Mines Group Ltd
ASX:WMG
|
AU |
|
Randon SA Implementos e Participacoes
BOVESPA:RAPT4
|
BR |
|
A
|
Altria Group Inc
BMV:MO
|
US |
|
X
|
Xpeng Inc
OTC:XPNGF
|
CN |
|
A
|
Anuh Pharma Ltd
BSE:506260
|
IN |
|
G
|
GreenPower Motor Company Inc
NASDAQ:GP
|
CA |
|
Vaxxinity Inc
OTC:VAXX
|
US |
|
O
|
OSK Holdings Bhd
KLSE:OSK
|
MY |
|
TechnologyOne Ltd
ASX:TNE
|
AU |
|
U
|
US Ecology Inc
F:3ER
|
US |
|
S
|
Santander Bank Polska SA
WSE:SPL
|
PL |
|
Y
|
Yijia Group Corp
OTC:YJGJ
|
HK |
|
C
|
Cowell e Holdings Inc
HKEX:1415
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MCOV B's stock price target?
Not Available
MCOV B doesn't have any price targets made by Wall Street professionals.
What is Medicover AB's Revenue forecast?
Projected CAGR
12%
For the last 9 years the
compound annual growth rate for
Medicover AB's revenue is
19%.
The projected
CAGR
for the next 3 years is
12%.
What is Medicover AB's Operating Income forecast?
Projected CAGR
24%
For the last 9 years the
compound annual growth rate for
Medicover AB's operating income is
25%.
The projected
CAGR
for the next 3 years is
24%.
What is Medicover AB's Net Income forecast?
Projected CAGR
31%
For the last 9 years the
compound annual growth rate for
Medicover AB's net income is
32%.
The projected
CAGR
for the next 3 years is
31%.
